AGP Limited (PSX:AGP)

Market Cap	53.23B
Revenue (ttm)	25.03B
Net Income (ttm)	2.67B
Shares Out	280.00M
EPS (ttm)	9.53
PE Ratio	19.94
Forward PE	14.29
Dividend	4.00 (2.10%)
Ex-Dividend Date	Mar 27, 2025

Volume	90,560
Average Volume	615,850
Open	190.10
Previous Close	190.08
Day's Range	190.01 - 194.25
52-Week Range	70.70 - 204.90
Beta	0.41
RSI	58.56
Earnings Date	Apr 25, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products under licensing arrangements in Pakistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, a...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.